BIVI
BIVI
NASDAQ · Biotechnology

Biovie Inc

$1.66
+0.03 (+1.84%)
As of Sep 22, 5:41 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +1,657.8% upside
Low Target $17.82
Average Target $29.18
High Target $40.31
Current Price $1.66
Current
$1.66
Target
$29.18
$17.82 $29.18 avg $40.31
Scenario Analysis
Bear Case
$17.82
973.5%
Low target
Base Case
$29.18
+1,657.8%
Avg target
Bull Case
$40.31
+2,328.3%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$3.79
-56.2% from high
52-Week Low
$0.82
+102.4% from low
Target vs 52W High
$29.18
+669.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.9%
AMGN
Amgen Inc
Hold 43 47% $190.87 -53.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -14.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
Hold 30 37% $149.45 -18.1%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -63.4%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -40.8%